XTTRIUM LABS INC
SpecialtyXTTRIUM LABS INC is a specialty pharmaceutical company focused on Dermatology.
XTTRIUM LABS INC's Key Drugs
XTTRIUM LABS INC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
XTTRIUM LABS INC's Recent FDA Approvals
New NDA/BLA approvals for XTTRIUM LABS INC over the last two years — novel drugs only, excluding generics and label supplements.
XTTRIUM LABS INC's Therapeutic Areas
XTTRIUM LABS INC's approved drugs and pipeline span 1 therapeutic area, led by Dermatology, across 0 biologic and 3 small-molecule drugs. Weighted by commercial stage — approved drugs count most, then late-stage trials.
XTTRIUM LABS INC's Top Competitors
XTTRIUM LABS INC's closest competitors by therapeutic-area and drug-target overlap include Pfizer, Baxter, and Eli Lilly. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
XTTRIUM LABS INC Pipeline Snapshot
Active clinical trials for XTTRIUM LABS INC across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Dermatology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1984-12-24
- Latest
- 2026-02-03
- Applications
- 9